Lisheng Pharmaceuticals announced that the company recently received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for the drug apmister issued by the State Drug Administration. The API passed the marketing application for domestically produced chemical raw materials. Apomistel is mainly used to treat adult patients with moderate to severe plaque psoriasis.

Zhitongcaijing · 10/17 07:49
Lisheng Pharmaceuticals announced that the company recently received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for the drug apmister issued by the State Drug Administration. The API passed the marketing application for domestically produced chemical raw materials. Apomistel is mainly used to treat adult patients with moderate to severe plaque psoriasis.